Have the EAGLES landed? Safety of varenicline, bupropion and NRT in smokers with and without mental illnesses


Paul Christiansen presents the results of the EAGLES RCT into the neuropsychiatric safety and efficacy of varenicline, bupropion, and nicotine patches in smokers with and without psychiatric disorders.

[read the full story...]

Can pharmacotherapy help smokers with severe mental disorders?


Andrew Jones reports on an ecological pragmatic clinical trial, which suggests that it is feasible to support smoking cessation in people with severe mental disorders such as bipolar disorder and schizophrenia.

[read the full story...]

Nicotine without smoke: new RCP report on e-cigarettes and tobacco harm reduction


Debutant blogger and vaping activist Lorien Jollye presents a new tobacco harm reduction report from the Tobacco Advisory Group of the Royal College of Physicians.

[read the full story...]

Nicotine patches, Varenicline and combination NRT: as good/bad as each other?


Paul Christiansen considers the findings of a recent RCT, which evaluates the effects of nicotine patches versus varenicline versus combination nicotine replacement therapy on smoking cessation at 26 weeks.

[read the full story...]

Smoking and chronic mental illness: what’s the best way to quit or cut down?


Meg Fluharty considers the findings of a BMJ State of the Art review, which looks at the evidence for smoking cessation in people with chronic mental illness such as schizophrenia, unipolar depression, bipolar depression, anxiety disorders and PTSD.

[read the full story...]

Smokeless tobacco – do behavioural and pharmacological interventions help users quit?

shutterstock_32414035 - Betel leaf

Dominic Hurst looks at the recent Cochrane review of interventions to help smokeless tobacco (ST) users quit. ST use is linked to oral cancer, precancer and periodontal disease, so dentists have an important role in encouraging users to quit.

[read the full story...]

Smoking cessation for people with severe mental illness


Sally Adams appraises and summarises the SCIMITAR pilot RCT, which investigates smoking cessation for people with severe mental ill health. The paper presents a highly promising bespoke intervention for smokers with bipolar disorder, psychosis or schizophrenia.

[read the full story...]

The effect of smoke-free psychiatric hospitals on smoking behaviour: more evidence needed


Olivia Maynard appraises a recent systematic review, which investigates the impact of smoke-free psychiatric hospitals on patients’ motivations to quit and smoking behaviour.

[read the full story...]

Smoking cessation in the emergency setting


Olivia Maynard summarises a systematic review of smoking cessation interventions in the emergency setting, which highlights the poor quality and heterogenous nature of the published trials in this field.

[read the full story...]

E-cigarettes: a review of the evidence-base for regulation


Sally Adams summarises a recent review of e-cigarettes, which looks at use, content, safety, effects on smokers and the potential for harm and benefit.

[read the full story...]